Prediction of Undesired Obstruction in External Ventricular Drains.
NCT ID: NCT06466811
Last Updated: 2024-07-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
640 participants
OBSERVATIONAL
2024-07-04
2026-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Consequently, identifying high-risk patients and closely monitoring them is imperative. While IVH is known to increase the risk of obstruction in the natural cerebrospinal fluid outflow tract, its association with ventricular drain obstruction remains unproven.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Shunt Outcomes of Post-Hemorrhagic Hydrocephalus
NCT01480349
Ultrasound (US) Guided External Ventricular Catheter Placement
NCT06253858
Brain Ultrasound in the Weaning of External Ventricular Leads
NCT03531723
Endoscopic Third Ventriculostomy Versus Ventriculo-peritoneal Shunting in Idiopathic Normal Pressure Hydrocephalus
NCT03245138
Monitoring Patient Cerebro-Spinal Fluid Drainage With an Ultrasonic Flow Sensor
NCT00652197
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patients of intensive care unit
Patients of intensive care unit having an EVD
Patients of surgical intensive care unit
Patients of surgical intensive care unit having an EVD.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* admitted to the ICU,
* with first EVD inserted for less than 12 hours,
* and brain imaging (CT or MRI) available in the timespan "24 hours before to 24 hours after" the EVD insertion.
Exclusion Criteria
* purulent cerebrospinal fluid
* Pregnant or breast-feeding patient
* Moribund patient or patient with decision of withholding or withdrawing life-sustaining treatment within the 12 hours
* Patient with no health insurance
* Patient under guardianship
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nantes University Hospital
Nantes, Loire-Atlantique, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Karim LAKHAL, PH
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC24_0074
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.